A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorYan Li
About this trial
24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the European Society of Cardiology (ESC) guideline on ambulatory blood pressure monitoring. Finally, we should promote the clinical application of 24 hour ambulatory blood pressure monitoring to greatly improve the management level of hypertension in China and effectively reduce the risk caused by hypertension in the population.
Information of hypertensive patients with ambulatory blood pressure monitoring was prospectively registered nationwide,and then to investigate whether there was difference in cardiovascular prognosis according to the control of ABP.
Eligibility criteria
Qualifiers
Age 18-80 years old
Clinical diagnosed hypertension with the use of antihypertensive drugs
A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
Willing to provide information about disease history and blood biochemical test data within 6 months.
Disqualifiers
Without antihypertensive drug use
Hospitalized hypertension patients
Non-compliant patient
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Yan Li
Lead sponsor
Shanghai Institute of Hypertension
Sponsor institution
Source ClinicalTrials.gov